Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer.
Koutaro OnoRemi MuraseNatsumi MatsumotoYutaro KubotaHiroo IshidaKen-Ichi FujitaPublished in: Cancer chemotherapy and pharmacology (2024)
UMIN000013939, registered on May 12, 2014, when 6 months after the approval by the Institutional Review Board of Showa University.